These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34449650)

  • 1. Performance of Qualitative and Quantitative Antigen Tests for SARS-CoV-2 Using Saliva.
    Yokota I; Sakurazawa T; Sugita J; Iwasaki S; Yasuda K; Yamashita N; Fujisawa S; Nishida M; Konno S; Teshima T
    Infect Dis Rep; 2021 Aug; 13(3):742-747. PubMed ID: 34449650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron detection by antigen tests using saliva.
    Murakami K; Iwasaki S; Oguri S; Tanaka K; Suzuki R; Hayasaka K; Fujisawa S; Watanabe C; Konno S; Yokota I; Fukuhara T; Murakami M; Teshima T
    J Clin Virol Plus; 2022 Nov; 2(4):100109. PubMed ID: 36118305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
    Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
    Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
    Basso D; Aita A; Padoan A; Cosma C; Navaglia F; Moz S; Contran N; Zambon CF; Maria Cattelan A; Plebani M
    Clin Chim Acta; 2021 Jun; 517():54-59. PubMed ID: 33626369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis.
    Ishii T; Sasaki M; Yamada K; Kato D; Osuka H; Aoki K; Morita T; Ishii Y; Tateda K
    J Infect Chemother; 2021 Jun; 27(6):915-918. PubMed ID: 33676843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19.
    Asai N; Sakanashi D; Ohashi W; Nakamura A; Kawamoto Y; Miyazaki N; Ohno T; Yamada A; Chida S; Shibata Y; Kato H; Shiota A; Hagihara M; Koita I; Yamagishi Y; Suematsu H; Ohta H; Mikamo H
    J Infect Chemother; 2021 Jul; 27(7):1039-1042. PubMed ID: 33840598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance.
    Aita A; Navaglia F; Moz S; Contran N; Barbaro F; Cattelan AM; Padoan A; Cosma C; Faggian D; Plebani M; Basso D
    Clin Chem Lab Med; 2023 Jan; 61(2):323-331. PubMed ID: 36282616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.
    Yokota I; Shane PY; Teshima T
    Travel Med Infect Dis; 2021; 43():102127. PubMed ID: 34174408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.
    Sun Q; Li J; Ren H; Pastor L; Loginova Y; Madej R; Taylor K; Wong JK; Zhang Z; Zhang A; Lu CM; Sha MY
    PLoS One; 2021; 16(2):e0243183. PubMed ID: 33621263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort.
    Sasikala M; Sadhana Y; Vijayasarathy K; Gupta A; Daram SK; Podduturi NCR; Reddy DN
    BMC Infect Dis; 2021 Jul; 21(1):648. PubMed ID: 34225656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.
    Sakanashi D; Asai N; Nakamura A; Miyazaki N; Kawamoto Y; Ohno T; Yamada A; Koita I; Suematsu H; Hagihara M; Shiota A; Kurumiya A; Sakata M; Kato S; Muramatsu Y; Koizumi Y; Kishino T; Ohashi W; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Jan; 27(1):126-129. PubMed ID: 33060046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of false positives in the SARS-CoV-2 quantitative antigen test.
    Kobayashi R; Murai R; Moriai M; Nirasawa S; Yonezawa H; Kondoh T; Saeki M; Yakuwa Y; Sato Y; Katayama Y; Nakafuri H; Kitayama I; Asanuma K; Fujiya Y; Takahashi S
    J Infect Chemother; 2021 Oct; 27(10):1477-1481. PubMed ID: 34238663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen.
    Amendola A; Sberna G; Lalle E; Colavita F; Castilletti C; Menchinelli G; Posteraro B; Sanguinetti M; Ippolito G; Bordi L; Capobianchi MR; On Behalf Of Inmi Covid-Study Group
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR.
    Tsujimoto Y; Terada J; Kimura M; Moriya A; Motohashi A; Izumi S; Kawajiri K; Hakkaku K; Morishita M; Saito S; Takumida H; Watanabe H; Tsukada A; Morita C; Yamaguchi Y; Katsuno T; Kusaba Y; Sakamoto K; Hashimoto M; Suzuki M; Takasaki J; Hojo M; Miyoshi-Akiyama T; Sugiyama H
    Infect Dis (Lond); 2021 Aug; 53(8):581-589. PubMed ID: 33760699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
    Chen JH; Yip CC; Poon RW; Chan KH; Cheng VC; Hung IF; Chan JF; Yuen KY; To KK
    Emerg Microbes Infect; 2020 Dec; 9(1):1356-1359. PubMed ID: 32459137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients.
    Kandel C; Zheng J; McCready J; Serbanescu MA; Racher H; Desaulnier M; Powis JE; Vojdani K; Finlay L; Sheldrake E; Vermeiren C; Katz K; McGeer A; Kozak R; Goneau LW
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33212817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Hirotsu Y; Sugiura H; Maejima M; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Jul; 108():263-269. PubMed ID: 34082089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2.
    Kurihara Y; Kiyasu Y; Akashi Y; Takeuchi Y; Narahara K; Mori S; Takeshige T; Notake S; Ueda A; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2021 Oct; 27(10):1493-1497. PubMed ID: 34294528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.